Pregled bibliografske jedinice broj: 764513
FATAL INTOXICATION WITH QUETIAPINE AND NITRAZEPAM
FATAL INTOXICATION WITH QUETIAPINE AND NITRAZEPAM // Clinical Chemistry and Laboratory Medicine 2015 ; 53, Special Supplement, Poster Abstracts – Poster Abstracts – EuroMedLab Paris 2015 – Paris, 21-25 June 2015
Berlin: Walter de Gruyter, 2015. str. S1436-S1436 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 764513 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
FATAL INTOXICATION WITH QUETIAPINE AND NITRAZEPAM
Autori
Mandić, Sanja ; Pavošević, Tihana ; Šahinović, Ines ; Horvat, Vesna ; Mandić, Dario ; Lukić, Iva ; Šerić, Vatroslav
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Clinical Chemistry and Laboratory Medicine 2015 ; 53, Special Supplement, Poster Abstracts – Poster Abstracts – EuroMedLab Paris 2015 – Paris, 21-25 June 2015
/ - Berlin : Walter de Gruyter, 2015, S1436-S1436
Skup
21st IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine - EuroMedLab Paris 2015 – Paris, 21-25 June 2015
Mjesto i datum
Pariz, Francuska, 21.06.2015. - 25.06.2015
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
quetiapine; nitrazepam; intoxication
Sažetak
BACKGROUND-AIM Quetiapine is an antipsychotic drug used for the treatment of psychotic disorders. Nitrazepam is a benzodiazepine with sedative action. Both drugs are widely prescribed since they have been reported as relatively safe in overdose. This case report presents a fatal intoxication with Quetiapine and Nitrazepam. 53-year old man was admitted to the intensive care unit after taking unknown drugs in an attempted suicide. He was unconscious, febrile and hypotonic but without alterations in electrocardiogram. He was prescribed Quetiapine and Nitrazepam as regular therapy due to his medical history of posttraumatic stress disorder. METHODS Beside other laboratory analysis, drug screening was performed (VivaE ; Siemens). Confirmation analyses were performed using gas chromatography-mass spectrometry (GCMS–QP2010 Ultra ; Shimadzu) after liquid-liquid extraction. Finally, drug concentrations were measured by liquid chromatography-tandem mass spectrometry (LCMS/ MS –8040 ; Shimadzu). RESULTS Laboratory data on the day of admission revealed extremely high creatine kinase, myoglobin and D-dimmers, compensatory respiratory acidosis, hyperglycemia, the presence of alcohol and elevated liver enzymes with no evidence of kidney failure. Drug screen was positive for benzodiazepines and tricyclic antidepressant while confirmatory method with GCMS established presence of Quetiapine and Nitrazepam. Measured concentrations were 3.92 mg/L and 1.06 mg/L , respectively. The patient was extremely hemodynamically unstable and received high dose of noradrenaline. Because of consequently renal failure development he was dialyzed on the ninth day but despite that he arrested 10 days after admission. CONCLUSION Almost all laboratory results were in accordance with the findings disclosed in the literature after overdose with Quetiapine and Nitrazepam. Although drug concentrations were below lethal values described in the literature, their synergistic action together with alcohol led to lethal outcome. Both drugs cause central nervous system depression which may result in coma with possible fatal outcome as shown in this case.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Nastavni zavod za javno zdravstvo "Dr. Andrija Štampar",
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE